ConductScience.org, home

Paper901706

Pindolol, a beta-adrenoceptor blocking agent with a negligible first-pass effect.

Meier J and 1 other. Br J Clin Pharmacol, 1977. Cited by 21 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Pindolol, a beta-adrenoceptor blocking agent with a negligible first-pass effect. Papers, record 901706. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/901706

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Pindolol, a beta-adrenoceptor blocking agent with a negligible first-pass effect.
PubMed
Journal
Br J Clin Pharmacol
PubMed
Year
1977
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
21
iCite
Relative citation ratio, by iCite
1.35
iCite
Revised in PubMed
2019-05-09
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Meier JJ
2Nüesch EE

Source PubMed

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
PindololMajor topic
Administration, Oral
Biological Availability
Biotransformation
Humans
Injections, Intravenous
Kinetics
Male

Source PubMed

References11

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
113,958Clinical pharmacokinetics of beta-adrenoreceptor blocking drugs.Clin Pharmacokinet1976https://conductscience.org/library/papers/13958PubMed
2973,959beta-Adrenoceptor blocking activity and duration of action of pindolol and propranolol in healthy volunteers.Br J Clin Pharmacol1976https://conductscience.org/library/papers/973959PubMed
31,136,801Proceedings: "First-pass" effect and dose dependent availability as factors contributing to interindividual differences in equilibrium concentrations of alprenolol in man.Acta Pharm Suec1974https://conductscience.org/library/papers/1136801PubMed
45,567,579Influence of first-pass effect on availability of drugs on oral administration.J Pharm Sci1971https://conductscience.org/library/papers/5567579PubMed
54,390,683A method for the fluorimetric determination of 4-(2-hydroxy-3-isopropylaminopropoxy)-indole (LB46), a beta-blocking agent, in plasma and urine.Experientia1969https://conductscience.org/library/papers/4390683PubMed
6237,402Pharmacokinetics and biopharmaceutics of some adrenergic beta-receptor antagonists with special emphasis on alprenolol and metoprolol.Acta Pharmacol Toxicol (Copenh)1975https://conductscience.org/library/papers/237402PubMed
74,853,607Pharmacokinetics of unlabelled and 14C-labelled pindolol in uraemia.Eur J Clin Pharmacol1974https://conductscience.org/library/papers/4853607PubMed
84,853,602Pharmacokinetics of pindolol in man.Eur J Clin Pharmacol1974https://conductscience.org/library/papers/4853602PubMed
95,054,586The disposition of propranolol. I. Elimination during oral absorption in man.Pharmacology1972https://conductscience.org/library/papers/5054586PubMed
101,094,802Combined pharmacokinetic and pharmacodynammc studies in man of the adrenergic beta1-receptor antagonist metoprolol.Acta Pharmacol Toxicol (Copenh)1975https://conductscience.org/library/papers/1094802PubMed
111,137,681Proceedings: Biological and pharmacological myocardial elimination rate of propranolol.Br Heart J1975https://conductscience.org/library/papers/1137681PubMed

Cited by10

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 21 citations.

PMIDTitleJournalYearIn PapersSource
34,196,913Changes of Drug Pharmacokinetics in Patients with Short Bowel Syndrome: A Systematic Review.Eur J Drug Metab Pharmacokinet2021https://conductscience.org/library/papers/34196913PubMed
25,432,141Determining the mechanisms underlying augmented renal drug clearance in the critically ill: use of exogenous marker compounds.Crit Care2014https://conductscience.org/library/papers/25432141PubMed
7,286,035A pharmacodynamic and pharmacokinetic comparison of pindolol 20 mg retard and a conventional tablet.Eur J Clin Pharmacol1981https://conductscience.org/library/papers/7286035PubMed
7,117,354Metabolism of pindolol in patients with renal failure.Eur J Clin Pharmacol1982https://conductscience.org/library/papers/7117354PubMed
7,106,158Elimination of pindolol in liver disease.Eur J Clin Pharmacol1982https://conductscience.org/library/papers/7106158PubMed
7,104,143Effects of age and smoking on the pharmacokinetics of pindolol and propranolol.Br J Clin Pharmacol1982https://conductscience.org/library/papers/7104143PubMed
7,104,142Cardiac dose-response relationships of oral and intravenous pindolol.Br J Clin Pharmacol1982https://conductscience.org/library/papers/7104142PubMed
7,014,827A standard approach to compiling clinical pharmacokinetic data.J Pharmacokinet Biopharm1981https://conductscience.org/library/papers/7014827PubMed
6,487,506Study of the bioavailability of pindolol in malabsorption syndromes.Br J Clin Pharmacol1984https://conductscience.org/library/papers/6487506PubMed
6,125,169Pindolol--a beta-adrenoceptor blocking drug with partial agonist activity: clinical pharmacological considerations.Br J Clin Pharmacol1982https://conductscience.org/library/papers/6125169PubMed

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/901706

GET https://conductscience.org/api/papers/v1/901706/authors